137014-97-2

Upstream product

• 137014-96-1 Acetic acid (2R,3S,4R,5R,6S)-6-allyloxy-3-benzyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-5-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-ylmethyl ester 
• 138339-89-6 N-[(2S,3R,4R,5S,6R)-2-Allyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-5-hydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl]-2,2,2-trifluoro-acetamide 
• 132791-92-5 Allyl 3-O-<(3R)-3-benzyloxytetradecanyl>-2-deoxy-4,6-O-isopropylidene-2-trifluoroacetamido-α-D-glucopyranoside 
• 137014-95-0 Acetic acid (2R,3S,4R,5R,6S)-6-allyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-3-hydroxy-5-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-ylmethyl ester 

Downstream Products

• 137014-98-3 [(2R,3S,4R,5R,6S)-6-Allyloxy-5-amino-3-benzyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-tetrahydro-pyran-2-yl]-methanol 

Relevant academic research and scientific papers

Synthesis of a 3-ether analogue of lipid A

Lipid A 3-ether analogues were synthesized from allyl 2-deoxy-4,6-O-isopropylidene-2-trifluoroacetamido-α-D-glucopyranoside and 3,4,6-tri-O-acetyl-2-trifluoroacetamido-α-D-glucopyranosyl bromide.The compound lost completely the endotoxic activity.